| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 80,480 | 69,997 | 70,130 | 79,358 | | Cost of Revenue | 65,705 | 57,383 | 58,247 | 69,248 | | | Gross Profit | 14,775 | 12,614 | 11,883 | 10,110 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,854 | 8,677 | 9,010 | 9,138 | | Non Recurring | 185 | (87) | 3,470 | (293) | | Others | 2,094 | 1,835 | 1,719 | 1,713 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,642 | 2,189 | (2,316) | (448) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (11) | (192) | (48) | (331) | | Earnings Before Interest And Taxes | 2,631 | 1,997 | (2,364) | (779) | | Interest Expense | 517 | 539 | 535 | 639 | | Income Before Tax | 2,114 | 1,458 | (2,899) | (1,418) | | Income Tax Expense | 518 | 199 | 119 | (342) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,596 | 1,259 | (3,018) | (1,076) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,596 | 1,259 | (3,018) | (1,076) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,596 | $1,259 | ($3,018) | ($1,076) |
|
0.51% Nasdaq 
Income Statement
